Evening Resident Seminar: PGY2 Transplant Resident Seminar–02.20.2020
February 20, 2020
5:30 PM - 7:30 PM
Location
UIC College of Pharmacy--Chicago 134-1
Address
833 South Wood St., IL 60612
Cost
Free
Calendar
Download iCal FilePlease join us for our next evening Pharmacy Resident Seminar Presentation on Thursday, February 20, 2020, on the Chicago campus, Room 134-1 presented by Benito Valdepeñas , PharmD, RN and Anesia Reticker, PharmD. Registration is required in order to receive dinner. Registration now closed.
Type of Activity: An Knowledge-Based Activity Target Audience: Pharmacists
Location and Time: Thursday, February 20, 2020, 5:30 pm - 7:30 pm
- Live Presentation: UIC College of Pharmacy Chicago - Room 134-1
Agenda:
5:30 pm - 6:00 pm Welcome and Dinner (boxed dinners will be provided)
6:00 pm - 6:45 pm Breaking Bad Immunoglobulins in Highly Sensitized Candidates for Kidney Transplantation
Benito T. Valdepeñas III, PharmD, RN (PGY-2 Solid Transplant Pharmacy Practice Resident)
6:45 pm - 7:30 pm I Still Haven’t Found what I’m looking for: Clinical Trial Endpoints in the Treatment of Antibody Mediated Rejection
Anesia Reticker, PharmD (PGY-2 Solid Transplant Pharmacy Practice Resident)
Learning Objectives and CE information
Presentation Title: I Still Haven’t Found what I’m looking for: Clinical Trial Endpoints in the Treatment of Antibody Mediated Rejection
ACPE UAN# 0016-0000-20-008-L01-P, 0.75 contact hours (0.075 CEUs)
Learning Objectives:
At the completion of this activity, the participant will be able to:
- Describe the current treatment modalities and outcome measures in antibody mediated rejection in renal transplant recipients
- Explain the limitations of current efficacy endpoints used in antibody mediated rejection clinical trials
- Discuss future directions for the efficacy outcomes in the field of transplant
Presentation Title: Breaking Bad Immunoglobulins in Highly Sensitized Candidates for Kidney Transplantation
ACPE UAN#0016-0000-20-010-L01-P, 0.75 contact hours (0.075 CEUs)
Learning Objectives:
At the completion of this activity, the participant will be able to:
- Discuss the current situation of organ transplantation and the need for desensitization in sensitized individuals
- Discuss different desensitization strategies used to improve transplantation in highly sensitized candidates for kidney transplantation
- Review safety and efficacy data on the use of IdeS as a desensitization strategy in kidney transplantation
Fees: There is no charge for attending this activity. Registration now closed.
Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.
Date posted
Nov 22, 2019
Date updated
Feb 13, 2020